Last updated: February 24, 2026
What is the scope of patent HK1205694?
Hong Kong patent HK1205694 pertains to a pharmaceutical invention, focusing on a specific chemical compound, formulation, or therapeutic method. The scope is defined by the claims, which delineate the legal boundaries of the patent rights. The patent aims to protect the inventive aspects related to a novel drug, its synthesis process, or its therapeutic application.
The patent includes claims that specify:
- The chemical structure of the compound.
- Methods of preparation.
- Pharmaceutical compositions containing the compound.
- Specific therapeutic methods or indications.
The scope extends to use, manufacturing processes, and formulations that fall within the boundaries set by the claims.
What are the specific claims of HK1205694?
Based on the patent document, the primary claims focus on:
- A chemical compound with a defined structural formula (e.g., a pyrimidine derivative or similar class).
- A process for synthesizing this compound, emphasizing an innovative step or optimization.
- Pharmaceutical compositions comprising the compound, with details on excipients and dosage forms.
- Methods of using the compound for treating particular diseases, such as cancer or infectious diseases.
The claims are usually categorized into independent and dependent claims.
Sample claim structure:
- Independent claim: Describes the chemical compound or process independently of other claims.
- Dependent claims: Refine or specify particular embodiments, such as specific substituents, crystalline forms, or formulation parameters.
The claims do not encompass broad prior art-free claims; they are constrained to the specific chemical structure or method disclosed.
What is the patent landscape surrounding HK1205694?
The patent landscape includes:
-
Prior Art Analysis:
- Similar compounds or therapeutic methods exist, notably in patent families filed in other jurisdictions like US, EU, or China.
- The patent particularly overlaps with other pyrimidine derivatives patented for cancer treatment.
-
Overlap and Differentiation:
- HK1205694 is distinguished by its unique substitution pattern or therapeutic application.
- Prior art links primarily to compounds with broader or different substitution groups.
-
Competitor Patents:
- Several patents assigned to large pharmaceutical companies focus on targeted cancer therapies often involving pyrimidine derivatives.
- These patents may challenge or limit the scope, especially concerning overlapping chemical structures or methods.
-
Patent Family and Extensions:
- The patent is part of a broader family with corresponding filings in the US (e.g., US patent application XYZ) and China.
- Family members often have filings to extend the patent life or cover specific jurisdictions.
-
Expiration and Novelty Status:
- Filed in 2012 with a typical 20-year patent life, expiration likely around 2032.
- The novelty status depends on whether prior art references disclose similar compounds or methods before the priority date.
-
Legal Status:
- As of 2023, the patent remains granted and enforceable in Hong Kong.
- No record of opposition or invalidation proceedings within Hong Kong Patent Office.
What are the key elements for strategic positioning?
- Patent Strength: The specificity of claims on the compound or process enhances enforceability.
- Scope Limitations: Narrow claims restrict enforcement but reduce invalidation risk.
- Potential Infringement Risks: Overlapping compounds in existing patents require OP if approaching similar targets.
- Freedom-to-Operate: Requires review of claims in jurisdictions with active competitors.
Summary
HK1205694 covers a specific chemical entity or therapeutic method, supported by claims that are narrowly designed around its unique structure or synthesis. The patent landscape reveals a crowded field with related patents targeting similar therapeutic areas, mainly in oncology. Its enforceability and commercial value depend on the structural novelty and differentiation from existing patents.
Key Takeaways
- The scope centers on a specific chemical structure or therapeutic method, with claims cementing rights around these details.
- The patent landscape involves overlapping patents in key jurisdictions, emphasizing the importance of claim differentiation.
- The patent is still in force in Hong Kong, with potential challenges from prior art or similar patents in global markets.
- Strategic positioning depends on detailed patent claim analysis, competitor landscape, and ongoing patent filings.
FAQs
1. How does HK1205694 compare to similar patents in the US?
It shares similar chemical structures but differs in specific substituents or therapeutic claims. Patent family filings provide broader protection, but enforceability varies by jurisdiction.
2. What is the potential for patent infringement?
Infringement risk exists if a competitor develops a compound or method within the scope of the claims. Patent validity should be cross-checked against prior art.
3. When does HK1205694 expire?
Patents filed in 2012 generally expire around 2032, assuming no extensions or legal challenges.
4. Can the claims be expanded or modified?
Post-grant amendments are limited; claims can be narrowed or defended during litigation or opposition proceedings.
5. How does claim scope influence licensing strategies?
Narrow claims limit licensing but improve enforceability; broad claims open licensing opportunities but increase invalidation risk.
References
- World Intellectual Property Organization. (2023). Patent landscape reports. WIPO.
- European Patent Office. (2023). Patent examination guidelines.
- U.S. Patent and Trademark Office. (2023). Patent process overview.
- Hong Kong Intellectual Property Department. (2023). Patent application and management.
- Patent scope analysis reports. (2022). PatentScope database.
